FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4240952051> ?p ?o ?g. }

• W4240952051 endingPage "5047" @default.
• W4240952051 startingPage "5031" @default.
• W4240952051 abstract "TET family members (TETs) encode proteins that represent crucial factors in the active DNA demethylation pathway. Evidence has proved that TET2 mutation is associated with leukemogenesis, drug response, and prognosis in acute myeloid leukemia (AML). However, few studies revealed the TETs expression and its clinical significance in AML. We conducted a detailed expression and prognosis analysis of TETs expression in human AML cell lines and patients by using public databases. We observed that TETs expression especially TET2 and TET3 was closely associated with AML among various human cancers. TET1 expression was significantly reduced in AML patients, whereas TET2 and TET3 expression was significantly increased. Kaplan-Meier analysis showed that only TET3 expression was associated with overall survival (OS) and disease-free survival (DFS) among both total AML as well as non-M3 AML, and was confirmed by another independent cohort. Moreover, Cox regression analysis revealed that TET3 expression may act as an independent prognostic factor for OS and DFS in total AML. Interestingly, patients that received hematopoietic stem cell transplantation (HSCT) did not show significantly longer OS and DFS than those who did not receive HSCT in TET3 high-expressed groups; whereas, in TET3 low-expressed groups, patients that accepted HSCT showed significantly longer OS and DFS than those who did not accept HSCT. By bioinformatics analysis, TET3 expression was found positively correlated with tumor suppressor gene including CDKN2B, ZIC2, miR-196a, and negatively correlated with oncogenes such as PAX2 and IL2RA. Our study demonstrated that TETs showed significant expression differences in AML, and TET3 expression acted as a potential prognostic biomarker in AML, which may guide treatment choice between chemotherapy and HSCT." @default.
• W4240952051 created "2022-05-12" @default.
• W4240952051 creator A5009147079 @default.
• W4240952051 creator A5015150059 @default.
• W4240952051 creator A5041547862 @default.
• W4240952051 creator A5047088119 @default.
• W4240952051 date "2020-03-25" @default.
• W4240952051 modified "2023-09-27" @default.
• W4240952051 title "Expression and prognosis analysis of TET family in acute myeloid leukemia" @default.
• W4240952051 cites W1255676896 @default.
• W4240952051 cites W1964809738 @default.
• W4240952051 cites W1981463058 @default.
• W4240952051 cites W1997453048 @default.
• W4240952051 cites W2015678735 @default.
• W4240952051 cites W2033300046 @default.
• W4240952051 cites W2043398720 @default.
• W4240952051 cites W2060079012 @default.
• W4240952051 cites W2060446375 @default.
• W4240952051 cites W2072694918 @default.
• W4240952051 cites W2073872690 @default.
• W4240952051 cites W2092812546 @default.
• W4240952051 cites W2106876831 @default.
• W4240952051 cites W2108664872 @default.
• W4240952051 cites W2111593849 @default.
• W4240952051 cites W2114144492 @default.
• W4240952051 cites W2129443011 @default.
• W4240952051 cites W2169012047 @default.
• W4240952051 cites W2325267338 @default.
• W4240952051 cites W2345703104 @default.
• W4240952051 cites W2417729178 @default.
• W4240952051 cites W2418597951 @default.
• W4240952051 cites W2559921183 @default.
• W4240952051 cites W2568079045 @default.
• W4240952051 cites W2599477375 @default.
• W4240952051 cites W2602350817 @default.
• W4240952051 cites W2607129810 @default.
• W4240952051 cites W2746871805 @default.
• W4240952051 cites W2771968670 @default.
• W4240952051 cites W2786755330 @default.
• W4240952051 cites W2791744951 @default.
• W4240952051 cites W2793693835 @default.
• W4240952051 cites W2800986717 @default.
• W4240952051 cites W2811407868 @default.
• W4240952051 cites W2900786673 @default.
• W4240952051 cites W2919377570 @default.
• W4240952051 cites W2922605751 @default.
• W4240952051 cites W2955294350 @default.
• W4240952051 cites W2956609481 @default.
• W4240952051 cites W3190412754 @default.
• W4240952051 doi "https://doi.org/10.18632/aging.102928" @default.
• W4240952051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32209730" @default.
• W4240952051 hasPublicationYear "2020" @default.
• W4240952051 type Work @default.
• W4240952051 citedByCount "15" @default.
• W4240952051 countsByYear W42409520512020 @default.
• W4240952051 countsByYear W42409520512021 @default.
• W4240952051 countsByYear W42409520512022 @default.
• W4240952051 countsByYear W42409520512023 @default.
• W4240952051 crossrefType "journal-article" @default.
• W4240952051 hasAuthorship W4240952051A5009147079 @default.
• W4240952051 hasAuthorship W4240952051A5015150059 @default.
• W4240952051 hasAuthorship W4240952051A5041547862 @default.
• W4240952051 hasAuthorship W4240952051A5047088119 @default.
• W4240952051 hasBestOaLocation W42409520511 @default.
• W4240952051 hasConcept C104317684 @default.
• W4240952051 hasConcept C126322002 @default.
• W4240952051 hasConcept C143998085 @default.
• W4240952051 hasConcept C150194340 @default.
• W4240952051 hasConcept C16824249 @default.
• W4240952051 hasConcept C190727270 @default.
• W4240952051 hasConcept C2778461978 @default.
• W4240952051 hasConcept C2778729363 @default.
• W4240952051 hasConcept C2779282312 @default.
• W4240952051 hasConcept C2911091166 @default.
• W4240952051 hasConcept C502942594 @default.
• W4240952051 hasConcept C50382708 @default.
• W4240952051 hasConcept C54355233 @default.
• W4240952051 hasConcept C71924100 @default.
• W4240952051 hasConcept C86803240 @default.
• W4240952051 hasConceptScore W4240952051C104317684 @default.
• W4240952051 hasConceptScore W4240952051C126322002 @default.
• W4240952051 hasConceptScore W4240952051C143998085 @default.
• W4240952051 hasConceptScore W4240952051C150194340 @default.
• W4240952051 hasConceptScore W4240952051C16824249 @default.
• W4240952051 hasConceptScore W4240952051C190727270 @default.
• W4240952051 hasConceptScore W4240952051C2778461978 @default.
• W4240952051 hasConceptScore W4240952051C2778729363 @default.
• W4240952051 hasConceptScore W4240952051C2779282312 @default.
• W4240952051 hasConceptScore W4240952051C2911091166 @default.
• W4240952051 hasConceptScore W4240952051C502942594 @default.
• W4240952051 hasConceptScore W4240952051C50382708 @default.
• W4240952051 hasConceptScore W4240952051C54355233 @default.
• W4240952051 hasConceptScore W4240952051C71924100 @default.
• W4240952051 hasConceptScore W4240952051C86803240 @default.
• W4240952051 hasIssue "6" @default.
• W4240952051 hasLocation W42409520511 @default.
• W4240952051 hasLocation W42409520512 @default.
• W4240952051 hasLocation W42409520513 @default.

• next